Analysis of long-term outcome of modified gastric bypass for type 2 diabetes mellitus in Chinese patients

Table 3 Comparison of combinations before and after laparoscopic gastric bypass surgery

Abnormalities	Preoperative (%)	5 years after surgery (%)	P value
Antihyperglycemic drug	37 (100)	11 (29.7)	0.001a
Antihypertensive drug	7 (18.9)	2 (5.4)	0.075
Dyslipidemia	18 (50.0)	9 (2.05)	0.028a
Transferase	9 (25.0)	0 (0)	0.002a
CREA	1 (2.8)	1 (2.9)	0.984
UA	2 (5.6)	5 (13.9)	0.429
HGB	1 (2.7)	6 (18.2)	0.038a
ALB	1 (2.7)	1 (2.9)	1.000
SF	1 (3.0)	8 (25.0)	0.013a
FA	0 (0)	0 (0)	-
VB12	1 (3.0)	3 (11.1)	0.318

^aP < 0.05, the differences are statistically significant when compared with the preoperative period.

CREA: Creatinine; UA: Uric acid; HGB: Haemoglobin; ALB: Albumin; SF: Serum ferritin; FA Folic acid; VB₁₂: Vitamin B₁₂.